Virtus ETF Advisers LLC Nurix Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,458 shares of NRIX stock, worth $44,919. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,458

Previous 5,512 37.26%

Holding current value

$44,919

Previous $123,000 47.15%

% of portfolio

0.03%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$18.64 - $28.14 $38,286 - $57,799	-2,054 Reduced 37.26%	3,458 $65,000
Q3 2024 Nov 14, 2024	BUY	$18.93 - $25.69 $1,911 - $2,594	101 Added 1.87%	5,512 $123,000
Q2 2024 Aug 14, 2024	SELL	$12.02 - $21.3 $51,469 - $91,206	-4,282 Reduced 44.18%	5,411 $112,000
Q1 2024 May 15, 2024	SELL	$7.77 - $15.66 $5,151 - $10,382	-663 Reduced 6.4%	9,693 $142,000
Q4 2023 Feb 15, 2024	BUY	$4.25 - $10.71 $5,716 - $14,404	1,345 Added 14.93%	10,356 $106,000
Q3 2023 Nov 07, 2023	SELL	$7.86 - $10.08 $7,081 - $9,082	-901 Reduced 9.09%	9,011 $70,000
Q2 2023 Aug 14, 2023	BUY	$8.7 - $13.28 $15,059 - $22,987	1,731 Added 21.16%	9,912 $99,000
Q1 2023 May 15, 2023	SELL	$8.56 - $13.26 $26,972 - $41,782	-3,151 Reduced 27.81%	8,181 $72,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $14.59 $5,117 - $7,572	519 Added 4.8%	11,332 $124,000
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $961 - $1,545	78 Added 0.73%	10,813 $141,000
Q2 2022 Aug 12, 2022	BUY	$7.88 - $14.82 $39,864 - $74,974	5,059 Added 89.13%	10,735 $136,000
Q1 2022 May 16, 2022	SELL	$12.94 - $29.65 $4,321 - $9,903	-334 Reduced 5.56%	5,676 $80,000
Q4 2021 Feb 14, 2022	SELL	$26.43 - $34.5 $31,266 - $40,813	-1,183 Reduced 16.45%	6,010 $174,000
Q3 2021 Nov 15, 2021	SELL	$22.71 - $36.69 $8,561 - $13,832	-377 Reduced 4.98%	7,193 $216,000
Q2 2021 Aug 10, 2021	BUY	$24.21 - $35.89 $183,269 - $271,687	7,570 New	7,570 $201,000

Others Institutions Holding NRIX

# of Institutions

185

Shares Held

70.6M

Call Options Held

318K

Put Options Held

42.4K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $612M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Nurix Therapeutics, Inc. Transaction History